Thomas J. Lynch
Dr. Thomas Lynch joined Bristol-Myers Squibb in March 2017 as Chief Scientific Officer to lead the Research & Development organization, bringing broad leadership experience, significant experience in drug development, and a deep understanding of the patient perspective as a treating oncologist. He previously served as a director on Bristol-Myer Squibb’s board from 2013-2017. Tom hasRead more..